Citi lowered the firm’s price target on Opthea to $10 from $12 and keeps a Buy rating on the shares. The analyst cites dilution from recent financings for the target cut.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPT:
- Opthea to have presence at 24th EURETINA Congress
- Opthea to Have Significant Presence at the 24ᵗʰ EURETINA Congress and EURETINA Innovation Spotlight
- Opthea’s Sozinibercept Eyes Breakthrough in AMD Therapy
- Opthea Prepares for Phase 3 Results with Leadership Revamp
- Opthea announces executive leadership changes and senior hires